Ananda Developments #ANA – DJT Plants’ Cannabis Flower approved for Israel Import
Ananda, which is creating UK-based operations to grow and provide carbon neutral, consistent, high quality medical cannabis for the UK and international markets, announces that the Government of Israel has granted a licence for cannabis flower grown at Ananda’s subsidiary, DJT Plants Limited (“DJT Plants”) to be imported into Israel. The licence is held by […]
Ananda Developments #ANA – Total Voting Rights Announcement
TOTAL VOTING RIGHTS In accordance with the Financial Conduct Authority’s Disclosure and Transparency Rules, Ananda announces that the Company has 794,665,248 Ordinary Shares in issue, each share carrying the right to one vote. This figure of 794,665,248 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they […]
Ananda Developments #ANA – Exercise of Warrants
Ananda announces that 163,369 ordinary shares of 0.2p each in the Company (“Ordinary Shares”) have been issued following the exercise of warrants at 0.45p per share. The proceeds received by the Company will be used for general working capital purposes. Application will be made for the new Ordinary Shares to be admitted to trading on […]
Ananda Developments #ANA – Board Change
Ananda announces that Peter Redmond has stepped down as a non-executive Director of the Company with effect from 23 August 2021. Mr Redmond was appointed to the Board of Ananda in June 2019, to represent the interests of URA Holdings plc (“URA”) following URA’s investment in the Company. Following the May 2021 distribution of URA’s […]
Ananda Developments #PLC – Update on Medical Cannabis Research Growing Facility
Ananda’s ambition is to be a UK-based grower of carbon neutral, consistent, high quality medical cannabis for domestic and international markets. In 2025, the UK medical cannabis market is expected to be worth £450m and the European market is expected to be worth £2.7bn. HIGHLIGHTS Construction works at DJT Plants Limited’s (“DJT Plants”) medical cannabis research […]
Ananda Developments #ANA – Update on Medical Cannabis Research Growing Facility
Ananda’s ambition is to be a UK-based grower of carbon neutral, consistent, high quality medical cannabis for domestic and international markets. In 2025, the UK medical cannabis market is expected to be worth £450m and the European market is expected to be worth £2.7bn. HIGHLIGHTS Construction works at DJT Plants Limited’s (“DJT Plants”) medical cannabis […]
Ananda Developments #ANA – Exercise of Warrants
Ananda announces that 663 ordinary shares of 0.2p each in the Company (“Ordinary Shares”) have been issued following the exercise of warrants at 0.45p per share. The proceeds received by the Company will be used for general working capital purposes. Application will be made for the new Ordinary Shares to be admitted to trading on […]
Ananda Developments #ANA – Result of Annual General Meeting and TVR
Ananda Developments plc is pleased to announce that all the Resolutions were duly passed at the Annual General Meeting of the Company held today. In accordance with the Financial Conduct Authority’s Disclosure and Transparency Rules, Ananda announces that the Company has 794,501,216 ordinary shares of 0.2p each in issue, each share carrying the right to […]
Ananda Developments #ANA – Issue of Equity
Ananda announces that 96,890 ordinary shares of 0.2p each in the Company (“Ordinary Shares”) have been issued following the exercise of warrants at 0.45p per share. The proceeds receivable by the Company will be used for general working capital purposes. Application will be made for the new Ordinary Shares to be admitted to trading on […]
Ananda Developments #ANA – Issue of Convertible Loan Notes
Ananda announces that the Company has raised £350,000 (gross) and received firm commitments for a further £200,000 (gross) of convertible loan notes (“CLNs”). The CLNs will be convertible into ordinary shares in the Company (“Ordinary Shares”) at a price of 1p per share and will have a fixed life of 2 years. The CLNs bear […]